Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation.
Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation.
复制标题
抑制 Caspase-1 通过抑制焦亡激活来改善缺血相关的血脑屏障功能障碍和完整性
DOI:
10.3389/fncel.2020.540669
复制
发表时间:
2020
影响因子:
5.3
通讯作者:
Huang M
中科院分区:
文献类型:
--
作者:
Liang Y;Song P;Chen W;Xie X;Luo R;Su J;Zhu Y;Xu J;Liu R;Zhu P;Zhang Y;Huang M
Ischemic cerebral infarction represents a significant cause of disability and death worldwide. Caspase-1 is activated by the NLRP3/ASC pathway and inflammasomes, thus triggering pyroptosis, a programmed cell death. In particular, this death is mediated by gasdermin D (GSDMD), which induces secretion of interleukin (IL)-1β and IL-18. Accordingly, inhibition of caspase-1 prevents the development and worsening of multiple neurodegenerative diseases. However, it is not clear whether inhibition of caspase-1 can preserve blood-brain barrier (BBB) integrity following cerebral infarction. This study therefore aimed at understanding the effect of caspase-1 on BBB dysfunction and its underlying mechanisms in permanent middle cerebral artery occlusion (MCAO). Our findings in rat models revealed that expression of caspase-1 was upregulated following MCAO-induced injury in rats. Consequently, pharmacologic inhibition of caspase-1 using vx-765 ameliorated ischemia-induced infarction, neurological deficits, and neuronal injury. Furthermore, inhibition of caspase-1 enhanced the encapsulation rate of pericytes at the ischemic edge, decreased leakage of both Evans Blue (EB) and matrix metalloproteinase (MMP) proteins, and upregulated the levels of tight junctions (TJs) and tissue inhibitors of metalloproteinases (TIMPs) in MCAO-injured rats. This in turn improved the permeability of the BBB. Meanwhile, vx-765 blocked the activation of ischemia-induced pyroptosis and reduced the expression level of inflammatory factors such as caspase-1, NLRP3, ASC, GSDMD, IL-1β, and IL-18. Similarly, vx-765 treatment significantly reduced the expression levels of inflammation-related receptor for advanced glycation end products (RAGE), high-mobility family box 1 (HMGB1), mitogen-activated protein kinase (MAPK), and nuclear factor-κB (NF-κB). Evidently, inhibition of caspase-1 significantly improves ischemia-associated BBB permeability and integrity by suppressing pyroptosis activation and the RAGE/MAPK pathway.
登录
查看更多内容
影响因子:
16.6
作者:
Flores J;Noël A;Foveau B;Lynham J;Lecrux C;LeBlanc AC
通讯作者:
LeBlanc AC
DOI:
10.1016/j.bbrc.2019.03.202
发表时间:
2019-05-28
影响因子:
3.1
作者:
Li, Qian;Dai, Zhenguo;Wang, Lihua
通讯作者:
Wang, Lihua
影响因子:
8.3
作者:
GARCIA, JH;WAGNER, S;HU, XJ
通讯作者:
HU, XJ
DOI:
10.1073/pnas.94.5.2007
发表时间:
1997-03-04
影响因子:
11.1
作者:
Hara, H;Friedlander, RM;Moskowitz, MA
通讯作者:
Moskowitz, MA
影响因子:
5
作者:
Gao, Cheng;Yan, Ya'nan;Tao, Luyang
通讯作者:
Tao, Luyang